Acetazolamide Capsule
NDC Package 70710-1591-3
Package Information
Acetazolamide capsules is acetazolamide is used to prevent and reduce the symptoms of altitude sickness. This formulation utilizes a capsule delivery system. Marketed by Zydus Pharmaceuticals (usa) Inc., this product is identified by NDC 70710-1591 and is authorized under FDA application ANDA205301.
Identification & Billing
- RxCUI: 562524 - acetaZOLAMIDE 500 MG 12HR Extended Release Oral Capsule
- RxCUI: 562524 - 12 HR acetazolamide 500 MG Extended Release Oral Capsule
- RxCUI: 562524 - acetazolamide 500 MG 12 HR Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70710 - Zydus Pharmaceuticals (usa) Inc.
- 70710-1591 - Acetazolamide
- 70710-1591-3 - 30 CAPSULE in 1 BOTTLE
- 70710-1591 - Acetazolamide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70710-1591). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70710-1591-3 identifies a specific commercial package of 30 capsule in 1 bottle of Acetazolamide, a human prescription drug labeled by Zydus Pharmaceuticals (usa) Inc.. This capsule is formulated for oral use and contains acetazolamide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals (usa) Inc. on May 08, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures).
How is this Zydus Pharmaceuticals (usa) Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710159103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.